Universal Screening for Vocal Fold Motion Impairment in Children Undergoing Congenital Cardiac Surgery
Vocal Fold Palsy, Dysphagia, Congenital Heart Disease in Children
About this trial
This is an interventional diagnostic trial for Vocal Fold Palsy
Eligibility Criteria
Inclusion Criteria:
- Children 18 and younger with congenital cardiac disease necessitating surgery
- Children 18 and younger whose parents have given and signed an informed consent and HIPAA Authorization as well as the assent of the patient
Exclusion Criteria:
- History of prior cardiac surgery
- Known history of VFMI prior to evaluation
- Children 18 and younger who do not survive the immediate postoperative course will be excluded.
- Further exclusion may be determined at the discretion of the Principal Investigator.
Sites / Locations
- Children's Healthcare of Atlanta
Arms of the Study
Arm 1
Arm 2
No Intervention
Active Comparator
Neonates with congenital cardiac disease (retrospective)
Neonates with congenital cardiac disease (prospective)
Medical records of all children 18 and under who underwent CCS (as defined by ICD-9-CM congenital heart disease procedure codes) from January 1, 2011 to December 31, 2016 will be reviewed. Those who developed VFMI following CCS as diagnosed on flexible fiberoptic laryngoscopy will be identified. Inpatient, outpatient and emergency department (ED) records will be studied for details on postoperative length of stay, time to diagnosis of VFMI, time to initiation of oral feeding, ED visits and readmissions for feeding/weight gain or respiratory issues, and otolaryngology intervention.
Eligible children with known congenital cardiac disease necessitating cardiothoracic surgery will undergo universal screening, i.e., laryngeal ultrasonography and flexible fiberoptic laryngoscopy with examination and video documentation of laryngeal function preoperatively (if they are not intubated and are stable enough to do so) and postoperatively with a 2.4mm flexible laryngoscope and portable ultrasound system while awake.